• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) fixed dose combination (FDC) tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – June 2013

Summary View

 

DRUG INTERACTIONS

Drugs with No Observed or Predicted Interactions with COMPLERA
  • No clinically significant drug interactions have been observed between rilpivirine and...digoxin, telaprevir…
Pharmacokinetics
  • Table 7 updated with digoxin and telaprevir information